V. Papez

First name

V.

Last name

Papez

Voss, E. A., Shoaibi, A., Lai, Y. H., Blacketer, C., Alshammari, T., Makadia, R., et al. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932

View

. Y. Tan, Y., Papez, V., Chang, W. H., Mueller, S. H., Denaxas, S., & Lai, A. G. (2022). Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(22)00186-6

View

Papez, V., Moinat, M., Payralbe, S., Asselbergs, F. W., Lumbers, R. T., Hemingway, H., et al. (2021). Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure. JAMIA Open. http://doi.org/10.1093/jamiaopen/ooab001

View